Anest. intenziv. Med. 2010;21(6):342-350

Thrombocytes in sepsisIntesive Care Medicine - Review Article

Karvunidis Thomas1,*, Chvojka Jiří1, Lysák Daniel2, Kroužecký Aleš1, Raděj Jaroslav1, Novák Ivan1, Matějovič Martin1,*
1 I. interní klinika, Jednotka intenzivní péče, Univerzita Karlova v Praze, Lékařská fakulta v Plzni a Fakultní nemocnice Plzeň
2 Hematologicko-onkologické oddělení, Fakultní nemocnice Plzeň

Sepsis and septic shock are the most frequent causes of death in intensive care units. Thrombocytopenia and/or platelet function impairment are common parts of the multiple organ dysfunction syndrome. However, thrombocytes are not mere bystanders as documented in the present literature. Platelets, primary actors in haemostasis and thrombin generation during endothelial integrity disruption, similarly to leukocytes, maintain important functions of innate defense mechanisms of the host. These cellular fragments express and secrete numbers of adhesive and pro-inflammatory molecules that serve to initiate and modulate the primary immune response. Such haemostatic and especially non-haemostatic functions of platelets and their role in the pathogenesis of systemic inflammation will be discussed in this review.

Keywords: platelets; sepsis; innate immunity; intercellular interaction

Received: August 3, 2010; Accepted: September 21, 2010; Published: December 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Karvunidis T, Chvojka J, Lysák D, Kroužecký A, Raděj J, Novák I, Matějovič M. Thrombocytes in sepsis. Anest. intenziv. Med. 2010;21(6):342-350.
Download citation

References

  1. Martin, G. S., Mannino, D. M., Eaton, S. et al. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med., 2003, 348, p. 1546-1554. Go to original source... Go to PubMed...
  2. Annane, D., Bellissant, E., Cavaillon, J. M. Septic shock. Lancet, 2005, 365, p. 63-78. Go to original source... Go to PubMed...
  3. Folman, C. C., Linthorst, G. E., van, M. J. et al. Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis? Thromb. Haemost., 2000, 83, p. 923-930. Go to original source... Go to PubMed...
  4. Stohlawetz, P., Folman, C. C., von dem Borne, A. E. et al. Effects of endotoxemia on thrombopoiesis in men. Thromb. Haemost., 1999, 81, p. 613-617. Go to original source... Go to PubMed...
  5. Kaushansky, K. Thrombopoietin. N. Engl. J. Med., 1998, 339, p. 746-754. Go to original source... Go to PubMed...
  6. Jurk, K., Kehrel, B. E. Platelets: physiology and biochemistry. Semin. Thromb. Hemost., 2005, 31, p. 381-392. Go to original source... Go to PubMed...
  7. Smyth, S. S., McEver, R. P., Weyrich, A. S. et al. Platelet functions beyond hemostasis. J. Thromb. Haemost., 2009, 7, p. 1759-1766. Go to original source... Go to PubMed...
  8. Levi, M. Platelets. Crit. Care Med., 2005, 33, p. S523-S525. Go to original source... Go to PubMed...
  9. Levi, M. Platelets at a crossroad of pathogenic pathways in sepsis. J. Thromb. Haemost., 2004, 2, p. 2094-2095. Go to original source... Go to PubMed...
  10. Vincent, J. L., Yagushi, A., Pradier, O. Platelet function in sepsis. Crit. Care Med., 2002, 30, p. S313-S317. Go to original source... Go to PubMed...
  11. Vanderschueren, S., De, W. A., Malbrain, M. et al. Thrombocytopenia and prognosis in intensive care. Crit. Care Med., 2000, 28, p. 1871-1876. Go to original source... Go to PubMed...
  12. Strauss, R., Wehler, M., Mehler, K. et al. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit. Care Med., 2002, 30, p. 1765-1771. Go to original source... Go to PubMed...
  13. Akca, S., Haji-Michael, P., de, M. A. et al. Time course of platelet counts in critically ill patients. Crit. Care Med., 2002, 30, p. 753-756. Go to original source... Go to PubMed...
  14. Francois, B., Trimoreau, F., Vignon, P. et al. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am. J. Med., 1997, 103, p. 114-120. Go to original source... Go to PubMed...
  15. Zimmerman, G. A., McIntyre, T. M., Prescott, S. M. et al. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit. Care Med., 2002, 30, p. S294-S301. Go to original source... Go to PubMed...
  16. Weyrich, A. S., Zimmerman, G. A. Platelets: signaling cells in the immune continuum. Trends Immunol., 2004, 25, p. 489-495. Go to original source... Go to PubMed...
  17. Levi, M., Lowenberg, E. C. Thrombocytopenia in critically ill patients. Semin. Thromb. Hemost., 2008, 34, p. 417-424. Go to original source... Go to PubMed...
  18. Oppenheim-Eden, A., Glantz, L., Eidelman, L. A. et al. Spontaneous intracerebral hemorrhage in critically ill patients: incidence over six years and associated factors. Intensive Care Med., 1999, 25, p. 63-67. Go to original source... Go to PubMed...
  19. Russwurm, S., Vickers, J., Meier-Hellmann, A. et al. Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock, 2002, 17, p. 263-268. Go to original source... Go to PubMed...
  20. Levi, M. Platelets in sepsis. Hematology., 2005, 10 Suppl 1, p. 129-131. Go to original source... Go to PubMed...
  21. Levi, M. Platelets. Crit. Care Med., 2005, 33, p. S523-S525. Go to original source... Go to PubMed...
  22. Zarbock, A., Polanowska-Grabowska, R. K., Ley, K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev., 2007, 21, p. 99-111. Go to original source... Go to PubMed...
  23. von Hundelshausen, P., Weber, C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ. Res., 2007, 100, p. 27-40. Go to original source... Go to PubMed...
  24. Semple, J. W., Freedman, J. Platelets and innate immunity. Cell Mol. Life Sci., 2010, 67, p. 499-511. Go to original source... Go to PubMed...
  25. Fox, J. E. The platelet cytoskeleton. Thromb. Haemost., 1993, 70, p. 884-893. Go to original source... Go to PubMed...
  26. Puccetti, L., Pasqui, A. L., Pastorelli, M. et al. Platelet hyperactivity after statin treatment discontinuation. Thromb. Haemost., 2003, 90, p. 476-482. Go to original source... Go to PubMed...
  27. Yaguchi, A., Lobo, F. L., Vincent, J. L. et al. Platelet function in sepsis. J. Thromb. Haemost., 2004, 2, p. 2096-2102. Go to original source... Go to PubMed...
  28. Weyrich, A. S., Schwertz, H., Kraiss, L. W. et al. Protein synthesis by platelets: historical and new perspectives. J. Thromb. Haemost., 2009, 7, p. 241-246. Go to original source... Go to PubMed...
  29. van der Flier, M., van Leeuwen, H. J., van Kessel, K. P. et al. Plasma vascular endothelial growth factor in severe sepsis. Shock, 2005, 23, p. 35-38. Go to original source... Go to PubMed...
  30. Yano, K., Liaw, P. C., Mullington, J. M. et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J. Exp. Med., 2006, 203, p. 1447-1458. Go to original source... Go to PubMed...
  31. Annane, D., Bellissant, E., Cavaillon, J. M. Septic shock. Lancet, 2005, 365, p. 63-78. Go to original source... Go to PubMed...
  32. Tsiotou, A. G., Sakorafas, G. H., Anagnostopoulos, G. et al. Septic shock; current pathogenetic concepts from a clinical perspective. Med. Sci. Monit., 2005, 11, p. RA76-RA85.
  33. Brown, K. A., Brain, S. D., Pearson, J. D. et al. Neutrophils in development of multiple organ failure in sepsis. Lancet, 2006, 368, p. 157-169. Go to original source... Go to PubMed...
  34. Elzey, B. D., Tian, J., Jensen, R. J. et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity, 2003, 19, p. 9-19. Go to original source... Go to PubMed...
  35. Annane, D., Bellissant, E., Cavaillon, J. M. Septic shock. Lancet, 2005, 365, p. 63-78. Go to original source... Go to PubMed...
  36. Matsuda, N., Hattori, Y. Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy. J. Pharmacol. Sci., 2006, 101, p. 189-198. Go to original source... Go to PubMed...
  37. McGettrick, A. F., O'Neill, L. A. Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis. Br. J. Haematol., 2007, 139, p. 185-193. Go to original source... Go to PubMed...
  38. Shiraki, R., Inoue, N., Kawasaki, S. et al. Expression of Toll-like receptors on human platelets. Thromb. Res., 2004, 113, p. 379-385. Go to original source... Go to PubMed...
  39. Andonegui, G., Kerfoot, S. M., McNagny, K. et al. Platelets express functional Toll-like receptor-4. Blood, 2005, 106, p. 2417-2423. Go to original source... Go to PubMed...
  40. Beaulieu, L. M., Freedman, J. E. The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes. Thromb. Res., 2010, 125, p. 205-209. Go to original source... Go to PubMed...
  41. Ishii, K. J., Akira, S. Toll-like Receptors and Sepsis. Curr. Infect. Dis. Rep., 2004, 6, p. 361-366. Go to original source... Go to PubMed...
  42. Aslam, R., Speck, E. R., Kim, M. et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood, 2006, 107, p. 637-641. Go to original source... Go to PubMed...
  43. Alves-Filho, J. C. Toll-like receptors on platelets: the key for disseminated intravascular coagulation in sepsis? Thromb. Res., 2005, 115, p. 537-538. Go to original source... Go to PubMed...
  44. Jayachandran, M., Brunn, G. J., Karnicki, K. et al. In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. J. Appl. Physiol., 2007, 102, p. 429-433. Go to original source... Go to PubMed...
  45. Lewis, J. C., Maldonado, J. E., Mann, K. G. Phagocytosis in human platelets: localization of acid phosphatase-positive phagosomes following latex uptake. Blood, 1976, 47, p. 833-840. Go to original source...
  46. White, J. G. Platelets are covercytes, not phagocytes: uptake of bacteria involves channels of the open canalicular system. Platelets., 2005, 16, p. 121-131. Go to original source... Go to PubMed...
  47. Diacovo, T. G., deFougerolles, A. R., Bainton, D. F. et al. A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2. J. Clin. Invest, 1994, 94, p. 1243-1251. Go to original source... Go to PubMed...
  48. Peters, M. J., Heyderman, R. S., Hatch, D. J. et al. Investigation of platelet-neutrophil interactions in whole blood by flow cytometry. J. Immunol. Methods, 1997, 209, p. 125-135. Go to original source... Go to PubMed...
  49. Clark, S. R., Ma, A. C., Tavener, S. A. et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med., 2007, 13, p. 463-469. Go to original source... Go to PubMed...
  50. Brinkmann, V., Reichard, U., Goosmann, C. et al. Neutrophil extracellular traps kill bacteria. Science, 2004, 303, p. 1532-1535. Go to original source... Go to PubMed...
  51. Ma, A. C., Kubes, P. Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. J. Thromb. Haemost., 2008, 6, p. 415-420. Go to original source... Go to PubMed...
  52. Inwald, D. P., McDowall, A., Peters, M. J. et al. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ. Res., 2003, 92, p. 1041-1048. Go to original source... Go to PubMed...
  53. Henn, V., Slupsky, J. R., Grafe, M. et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature, 1998, 391, p. 591-594. Go to original source... Go to PubMed...
  54. Pignatelli, P., Sanguigni, V., Lenti, L. et al. gp91phox-dependent expression of platelet CD40 ligand. Circulation, 2004, 110, p. 1326-1329. Go to original source... Go to PubMed...
  55. Danese, S., de la, M. C., Reyes, B. M. et al. Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J. Immunol., 2004, 172, p. 2011-2015. Go to original source... Go to PubMed...
  56. Elzey, B. D., Tian, J., Jensen, R. J. et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity., 2003, 19, p. 9-19. Go to original source... Go to PubMed...
  57. Henn, V., Steinbach, S., Buchner, K. et al. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood, 2001, 98, p. 1047-1054. Go to original source... Go to PubMed...
  58. Clemetson, K. J. Platelets and pathogens. Cell Mol. Life Sci., 2010, 67, p. 495-498. Go to original source... Go to PubMed...
  59. Yeaman, M. R. Platelets in defense against bacterial pathogens. Cell Mol. Life Sci., 2010, 67, p. 525-544. Go to original source... Go to PubMed...
  60. Yeaman, M. R. Bacterial-platelet interactions: virulence meets host defense. Future. Microbiol., 2010, 5, p. 471-506. Go to original source... Go to PubMed...
  61. Kerrigan, S. W., Cox, D. Platelet-bacterial interactions. Cell Mol. Life Sci., 2010, 67, p. 513-523. Go to original source... Go to PubMed...
  62. Peng, J., Gygi, S. P. Proteomics: the move to mixtures. J. Mass Spectrom., 2001, 36, p. 1083-1091. Go to original source... Go to PubMed...
  63. Karvunidis, T., Mares, J., Thongboonkerd, V. et al. Recent progress of proteomics in critical illness. Shock, 2009, 31, p. 545-552. Go to original source... Go to PubMed...
  64. Garcia, A., Watson, S. P., Dwek, R. A. et al. Applying proteomics technology to platelet research. Mass Spectrom. Rev., 2005, 24, p. 918-930. Go to original source... Go to PubMed...
  65. Kor, D. J., Gajic, O. Blood product transfusion in the critical care setting. Curr. Opin. Crit. Care, 2010, 16, p. 309-316. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.